Developing a Novel Human Laboratory Paradigm for AUD Medication Screening (NCT06489782)

🧪 Interventions in This Study

• Model 1 (OTHER)
• Model 2 (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Yale University — New Haven, Connecticut

📞 Contact the Study Coordinator

Phone: (203) 737-2783

Email: meaghan.lavery@yale.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Alcohol Use Disorder

• Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism — Portland, Oregon
• Alcoholic Liver Disease and the Gut Microbiome — Los Angeles, California
• Telehealth Treatment for Alcohol Use Disorder — Stanford, California
• Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1 — Lexington, Kentucky
• Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder — Iowa City, Iowa
• rTMS in Older Adults With MCI and AUD — Charleston, South Carolina

Explore by condition: All Alcohol Use Disorder clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.